Authors:
TAMURA M
UEOKA H
KIURA K
TABATA M
SHIBAYAMA T
MIYATAKE K
GEMBA K
HIRAKI S
HARADA M
Citation: M. Tamura et al., PROGNOSTIC FACTORS OF SMALL-CELL LUNG-CANCER IN OKAYAMA LUNG-CANCER STUDY-GROUP TRIALS, Acta medica Okayama, 52(2), 1998, pp. 105-111
Authors:
KIURA K
WATARAI S
UEOKA H
TABATA M
GEMBA KI
AOE K
YAMANE H
YASUDA T
HARADA M
Citation: K. Kiura et al., AN ALTERATION OF GANGLIOSIDE COMPOSITION IN CISPLATIN-RESISTANT LUNG-CANCER CELL-LINE, Anticancer research, 18(4C), 1998, pp. 2957-2960
Authors:
MORITAKA T
KIURA K
UEOKA H
TABATA M
SEGAWA Y
SHIBAYAMA T
TAKIGAWA N
OHNOSHI T
HARADA M
Citation: T. Moritaka et al., CISPLATIN-RESISTANT HUMAN SMALL-CELL LUNG-CANCER CELL-LINE SHOWS COLLATERAL SENSITIVITY TO VINCA ALKALOIDS, Anticancer research, 18(2A), 1998, pp. 927-933
Authors:
UEOKA H
KIURA K
TABATA M
KAMEI H
GEMBA K
SAKAE K
HIRAKI Y
HIRAKI S
SEGAWA Y
HARADA M
Citation: H. Ueoka et al., A RANDOMIZED TRIAL OF HYBRID ADMINISTRATION OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE (CAV) CISPLATIN AND ETOPOSIDE (PVP) VERSUS SEQUENTIAL ADMINISTRATION OF CAV-PVP FOR THE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CARCINOMA - RESULTS OF LONG-TERM FOLLOW-UP, Cancer, 83(2), 1998, pp. 283-290
Authors:
HIRAKI A
TABATA M
UEOKA H
KIURA K
SHIBAYAMA T
YAMANE H
HARADA M
Citation: A. Hiraki et al., DIRECT INTRACEREBRAL INVASION FROM SKULL METASTASIS OF LARGE-CELL LUNG-CANCER, Internal medicine, 36(10), 1997, pp. 720-723
Authors:
KOHARA H
UEOKA H
TABATA M
SHINAGAWA K
HAYASHI K
HARADA M
Citation: H. Kohara et al., HIGH-DOSE ETOPOSIDE TREATMENT FOR CNS INVOLVEMENT IN A PATIENT WITH PRIMARY NON-HODGKINS-LYMPHOMA OF THE BREAST, Internal medicine, 36(10), 1997, pp. 738-741
Authors:
MATSUO K
KIURA K
UEOKA H
TABATA M
SHIBAYAMA T
MATSUMURA T
TAKIGAWA N
HIRAKI S
HARADA M
Citation: K. Matsuo et al., GROWTH-INHIBITORY EFFECTS OF ANTIFOLATES AGAINST AN ADRIAMYCIN-RESISTANT HUMAN SMALL-CELL LUNG-CANCER CELL-LINE, Acta medica Okayama, 51(3), 1997, pp. 121-127
Authors:
SEGAWA Y
TAKIGAWA N
KATAOKA M
TAKATA I
FUJIMOTO N
UEOKA H
Citation: Y. Segawa et al., RISK-FACTORS FOR DEVELOPMENT OF RADIATION PNEUMONITIS FOLLOWING RADIATION-THERAPY WITH OR WITHOUT CHEMOTHERAPY FOR LUNG-CANCER, International journal of radiation oncology, biology, physics, 39(1), 1997, pp. 91-98
Citation: H. Ueoka et A. Hase, TONOPLAST H-ARTICHOKE (HELIANTHUS-TUBEROSUS)( PUMPS ARE ACTIVATED DURING CALLUS FORMATION OF TUBER TISSUES OF JERUSALEM), Physiologia Plantarum, 100(1), 1997, pp. 91-101
Authors:
TESHIMA T
SUNAMI K
BESSHO A
SHINAGAWA K
OMOTO E
UEOKA H
HARADA M
OHNO Y
MIYOSHI T
MIYAMOTO T
HIGUCHI M
Citation: T. Teshima et al., CIRCULATING IMMATURE CELL COUNTS ON THE HARVEST DAY PREDICT THE YIELDS OF CD34(-COLONY-STIMULATING FACTOR PLUS CHEMOTHERAPY-INDUCED MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELL() CELLS COLLECTED AFTER GRANULOCYTE), Blood, 89(12), 1997, pp. 4660-4661
Authors:
HOSHINO K
TANIGUCHI M
UEOKA H
OHKUWA M
CHIDA C
MOROHASHI S
SASAKURA T
Citation: K. Hoshino et al., REPEATED UTILIZATION OF BETA-GLUCOSIDASE IMMOBILIZED ON A REVERSIBLY SOLUBLE-INSOLUBLE POLYMER FOR HYDROLYSIS OF PHLORHIZIN AS A MODEL REACTION PRODUCING A WATER-INSOLUBLE PRODUCT, Journal of fermentation and bioengineering, 82(3), 1996, pp. 253-258
Authors:
KATAOKA M
MORISHITA R
HIRAMATSU J
UEOKA H
NAKATA Y
OHNOSHI T
KIMURA I
HARADA M
Citation: M. Kataoka et al., OK-432 INDUCES PRODUCTION OF NEUTROPHIL CHEMOTACTIC FACTORS IN MALIGNANT PLEURAL EFFUSION, Internal medicine, 34(5), 1995, pp. 352-356
Authors:
HASHIMOTO T
OHTAKI M
UEOKA H
MUNAKA M
KURAMOTO A
KAMADA N
Citation: T. Hashimoto et al., ESTIMATION OF CHRONIC PHASE DURATION IN PH-POSITIVE CHRONIC MYELOCYTIC-LEUKEMIA TREATED WITH BUSULFAN - STATISTICAL-ANALYSIS ON JAPANESE PATIENTS, International journal of hematology, 60(1), 1994, pp. 59-69
Authors:
OHNOSHI T
HIRAKI S
UEDA N
FUJII M
MACHIDA K
UEOKA H
YONEI T
KIURA K
KAMEI H
SEGAWA Y
TABATA M
SHIBAYAMA T
MIYATAKE K
MAEDA T
KIMURA I
Citation: T. Ohnoshi et al., LONG-TERM RESULTS OF COMBINATION CHEMOTHERAPY WITH OR WITHOUT IRRADIATION IN SMALL-CELL LUNG-CANCER - A 5-YEAR TO 11-YEAR FOLLOW-UP, Internal medicine, 32(3), 1993, pp. 215-220
Authors:
YONEI T
OHNOSHI T
HIRAKI S
UEOKA H
KIURA K
MORITAKA T
SHIBAYAMA T
TABATA M
SEGAWA Y
TAKIGAWA N
KIMURA I
Citation: T. Yonei et al., ANTITUMOR-ACTIVITY OF PLATINUM ANALOGS AGAINST HUMAN LUNG-CANCER CELL-LINES AND TUMOR SPECIMENS, Acta medica Okayama, 47(4), 1993, pp. 233-241
Authors:
TABATA M
OHNOSHI T
UEOKA H
KIURA K
KIMURA I
Citation: M. Tabata et al., MDR1 GENE-EXPRESSION AND TREATMENT OUTCOME IN SMALL-CELL LUNG-CANCER - MDR1 GENE-EXPRESSION AS AN INDEPENDENT PROGNOSTIC FACTOR, Acta medica Okayama, 47(4), 1993, pp. 243-248
Citation: Y. Segawa et al., NEURAL CELL-ADHESION MOLECULE EXPRESSION AND CLINICAL-FEATURES IN SMALL-CELL LUNG-CANCER - A SEMIQUANTITATIVE IMMUNOHISTOCHEMICAL APPROACH USING AN IMMUNOGOLD-SILVER STAINING METHOD, Acta medica Okayama, 47(4), 1993, pp. 281-287
Authors:
SEGAWA Y
OHNOSHI T
HIRAKI S
UEOKA H
KIURA K
KAMEI H
TABATA M
SHIBAYAMA T
MIYATAKE K
GENBA K
MATSUMURA T
KIMURA I
Citation: Y. Segawa et al., IMMUNOHISTOCHEMICAL DETECTION OF P-GLYCOPROTEIN AND CARCINOEMBRYONIC ANTIGEN IN SMALL-CELL LUNG-CANCER - WITH REFERENCE TO PREDICTABILITY OF RESPONSE TO CHEMOTHERAPY, Acta medica Okayama, 47(3), 1993, pp. 181-189
Authors:
OHNOSHI T
HIRAKI S
FUJII M
UEOKA H
YONEI T
TAMURA M
MORITAKA T
MIMA Y
HORIGUCHI T
KIURA K
KAMEI H
KODANI T
HIRAKI Y
KIMURA I
Citation: T. Ohnoshi et al., MORTALITY AND MORBIDITY IN 2-YEAR DISEASE-FREE SURVIVORS OF SMALL-CELL LUNG-CANCER AFTER TREATMENT WITH COMBINATION CHEMOTHERAPY WITH OR WITHOUT IRRADIATION, Acta medica Okayama, 47(3), 1993, pp. 209-214
Authors:
OHONOSHI T
UEOKA H
KAWAHARA S
KIURA K
KAMEI H
HIRAKI Y
SEGAWA Y
HIRAKI S
KIMURA I
Citation: T. Ohonoshi et al., COMPARATIVE-STUDY OF PROPHYLACTIC CRANIAL IRRADIATION IN PATIENTS WITH SMALL-CELL LUNG-CANCER ACHIEVING A COMPLETE RESPONSE - A LONG-TERM FOLLOW-UP RESULT, Lung cancer, 10(1-2), 1993, pp. 47-54
Authors:
OHNOSHI T
HIRAKI S
UEOKA H
KIURA K
KAMEI H
HORIGUCHI T
KODANI T
MAEDA T
TABATA M
SHIBAYAMA T
SEGAWA Y
MIYATAKE K
TAKIGAWA N
KIMURA I
Citation: T. Ohnoshi et al., PILOT-STUDY OF HAMIDE-DOXORUBICIN-VINCRISTINE-CISPLATIN-ETOPOSIDE HYBRID CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, Cancer, 72(5), 1993, pp. 1597-1601